Navigation Links
Neurostimulation Therapy to ease cluster headaches

Scientists believe they may be on the right track in the treatment of cluster// headaches.

The key they say is stimulation of the occipital nerve.

This is done by implanting electrodes near the head and neck of the sufferers and giving them remotes to control the pulses.

The conclusions were reached separate research groups That included neurologists from the National Hospital for Neurology and Neurosurgery, in London, with University of California colleagues, as well as researchers from the Headache Research Unit of Belgium's Liege University.

During the research of the former, in one study, six out of eight patients studied said they got relief from cluster headaches while using the implanted electrodes.

Two out of eight patients in a second study said they were headache-free for more than a year using the device, and three more reported a 90-percent drop in the frequency of attacks.

Cluster headaches which are marked by periods with many attacks of extremely severe headaches are usually tackled by preventive medication every day for years. But in some cases, drugs do no good.

The use of brain stimulation in targeting a region called the posterior hypothalamus has been found quite effective yet it runs the dangerous risk of patients developing a fatal hemorrhage.

In the second body of work, Jean Schoenen and colleagues from the Headache Research Unit of Belgium's Liege University tested eight patients separately.

Two patients had no pain after 16 months and 22 months, respectively, and three more said they had 90 percent fewer headaches.

Says Peter Goadsby of University College London in Britain and the University of California, 'Occipital nerve stimulation in cluster headache seems to offer a safe, effective treatment option that could begin a new era of neurostimulation therapy for primary headache symptoms.'
ANN
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ODH, Inc.™ ... Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s ... PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ODH ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute for Palliative ... in or interested in palliative care education and research. The Symposium, “Innovate. Investigate. ... County San Diego on Sept. 28 and 29, 2017, on the campus of California ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... -- Genesis Healthcare Services has merged with Hospice Cloud, a ... Bill Monast , President and CEO of Hospice Cloud ... , executives with Home Health Depot, Inc., the parent ... This acquisition helps Hospice Cloud maintain its position as ... equipment (DME) solutions for the hospice industry. Nathan ...
Breaking Medicine Technology: